Home › Funds › Citigroup Inc › PTGX
Citigroup Inc position in PTGX
PROTAGONIST THERAPEUTICS INC · Health Care
Latest position (Q2 2026)198.67K sh
Reported value held$24.35M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 51.19K | $907.00K | New |
| Q4 2021 | 137.75K | $4.71M | Add |
| Q1 2022 | 35.66K | $844.00K | Reduce |
| Q2 2022 | 317.50K | $2.51M | Add |
| Q3 2022 | 315.19K | $2.66M | Reduce |
| Q4 2022 | 148.07K | $1.62M | Reduce |
| Q1 2023 | 217.75K | $5.01M | Add |
| Q2 2023 | 107.52K | $2.97M | Reduce |
| Q3 2023 | 147.83K | $2.47M | Add |
| Q4 2023 | 72.70K | $1.67M | Reduce |
| Q1 2024 | 208.64K | $6.04M | Add |
| Q2 2024 | 21.02K | $728.17K | Reduce |
| Q3 2024 | 73.49K | $3.31M | Add |
| Q4 2024 | 121.02K | $4.67M | Add |
| Q1 2025 | 121.84K | $5.89M | Add |
| Q2 2025 | 77.95K | $4.31M | Reduce |
| Q3 2025 | 152.58K | $10.14M | Add |
| Q4 2025 | 94.91K | $8.29M | Reduce |
| Q1 2026 | 158.71K | $16.73M | Add |
| Q2 2026 | 198.67K | $24.35M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PTGX
- BlackRock Inc 10.31M sh · $1.26B · Q2 2026
- Farallon Capital Management 6.35M sh · $778.25M · Q2 2026
- Vanguard Group 5.41M sh · $472.83M · Q4 2025
- Wellington Management Group 3.42M sh · $418.83M · Q2 2026
- UBS Group AG 3.40M sh · $416.68M · Q2 2026
- Janus Henderson Group 2.89M sh · $304.87M · Q1 2026
- Invesco Ltd 2.34M sh · $286.92M · Q2 2026
- Geode Capital Management 1.74M sh · $213.48M · Q2 2026
- Bank of America Corp 1.32M sh · $162.36M · Q2 2026
- Morgan Stanley 905.99K sh · $111.06M · Q2 2026
- Goldman Sachs Group 812.85K sh · $99.64M · Q2 2026
- Fidelity Management & Research (FMR) 672.19K sh · $82.40M · Q2 2026